尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Ali Al-Husry. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. Aggregated, 4 filings have been published. History available since 30 April 2025. The latest transaction was filed on 19 December 2025 (Grant). Regulator: RNS (LSE). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Ali Al-Husry is a declarant with 4 filings in total. The 4 sampled filings, all for Hikma Pharmaceuticals PLC, cover the period from 2025-04-30 to 2025-12-19 and concern grants, with no buy or sell amount reported in euros. He is listed as Non-Executive Director at Hikma Pharmaceuticals PLC.